During the past decade, Houston Clinical Trials, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Clinical Trials, LLC" #1 sponsor was "Shire" with 9 trials, followed by "Supernus Pharmaceuticals, Inc." with 6 trials sponsored, "Rhodes Pharmaceuticals, L.P." with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Arbor Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Clinical Trials, LLC" #1 collaborator was "Purdue Pharma LP" with 2 trials as a collaborator and "Purdue Pharma, Canada" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Houston Clinical Trials, LLC" are "ADHD" (7 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (6 trials), "Attention Deficit Hyperactivity Disorder" (3 trials), "Major Depressive Disorder" (3 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Houston Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Houston Clinical Trials, LLC" are "Drug" (26 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Dasotraline" (3 trials), "SHP465" (3 trials), "200mg SPN-812" (2 trials) and "PRC-063 25 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Houston Clinical Trials, LLC" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Houston Clinical Trials, LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Houston Clinical Trials, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Clinical Trials, LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".